Leadership
Leadership
Bimal Shah
Managing Director, Boston
Mr. Shah has focused on the life sciences and broader healthcare industry for over two decades, serving in senior corporate development and financial roles. Mr. Shah most recently was the Chief Financial Officer of Corium LLC, a commercial-stage biopharmaceutical company. Prior to joining Corium, he served as Senior Vice President, Corporate Finance and Strategy, for Sumitovant Biopharma, Inc., a wholly owned subsidiary of Sumitomo Pharmaceuticals Co., Ltd., one of Japan’s largest pharmaceutical companies.
Mr. Shah previously held business development, finance, and strategic commercial roles at Spectrum Pharmaceuticals, Inc. and Genentech Inc. (part of Roche). He also worked in the financial sector at Goldman Sachs, J.P. Morgan, and Warburg Pincus, where he was responsible for executing a wide range of deal transactions, including financings, investments, acquisitions, and alliances.
Mr. Shah currently serves on the board of directors and is chair of the audit committee of Anebulo Pharmaceuticals, Inc., a publicly traded biotech company.
Mr. Shah has advised many companies during his career and also served as an expert witness on multiple legal proceedings involving the pharmaceutical industry.
Mr. Shah received his Master’s in Business Administration, Master of Arts in International Policy Studies and Bachelor’s in Economics from Stanford University.